<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>1546-0096-6-S1-P6</ui>
   <ji>1546-0096</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis</p>
         </title>
         <aug>
            <au id="A1" ca="yes">
               <snm>Bayraktar</snm>
               <fnm>S</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Kasapcopur</snm>
               <fnm>O</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Arisoy</snm>
               <fnm>N</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Batar</snm>
               <fnm>B</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>Guven</snm>
               <fnm>M</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey</p>
            </ins>
         </insg>
         <source>Pediatric Rheumatology</source>
         <supplement>
            <title>
               <p>15<sup>th </sup>Paediatric Rheumatology European Society (PreS) Congress</p>
            </title>
            <editor>Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Micha&#235;l Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott</editor>
            <note>Meeting abstracts &#8211; A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/PDF/1546-0096-6-S1-full.pdf">here</a>.</note>
         </supplement>
         <conference>
            <title>
               <p>15<sup>th </sup>Paediatric Rheumatology European Society (PreS) Congress</p>
            </title>
            <location>London, UK</location>
            <date-range>14&#8211;17 September 2008</date-range>
            <url>http://www.pres.org.uk</url>
         </conference>
         <issn>1546-0096</issn>
         <pubdate>2008</pubdate>
         <volume>6</volume>
         <issue>Suppl 1</issue>
         <fpage>P6</fpage>
         <url>http://www.ped-rheum.com/content/6/S1/P6</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/1546-0096-6-S1-P6</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>15</day>
               <month>9</month>
               <year>2008</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2008</year>
         <collab>Bayraktar et al; licensee BioMed Central Ltd.</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>Juvenile idiopathic arthritis (JIA) is a complex, multifactorial and chronic inflammatory disease of unknown etiology with considerable variability in which tumor necrosis factor-alpha (TNF-&#945;) plays an important role. Both genetic and environmental factors can contribute to a susceptibility to disease initiation as well as a severity of disease course. TNF-&#945; polymorphisms may be an independent marker of susceptibility and severity of JIA. The aim of this study was to elucidate putative association between the -863 C/A polymorphism in the promoter region of the TNF-a gene and susceptibility to onset and severity of JIA.</p>
      </sec>
      <sec>
         <st>
            <p>Methods</p>
         </st>
         <p>We used PCR-RFLP (polymerase chain reaction &#8211; restriction fragment length polymorphism) method to detect the -863 C/A polymorphism. We analyzed DNA samples from 76 patients with JIA and 80 healthy individuals.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>The distribution of TNF-&#945; genotypes in cases differed significantly from that in the controls, comparing TNF-&#945; A carriers (CA or AA genotypes) with noncarriers (CC genotype) (OR = 2.49; 95% CI: 1.21&#8211;5.14; P = 0.01). However, TNF-&#945; -863 C/A allele frequencies were not significantly different between cases and controls.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>The TNF-&#945; CC genotype was associated with increased risk factor for JIA in a sample of Turkish patients.</p>
      </sec>
   </bdy>
</art>

